Interparfums Locks Cavalli Fragrance Rights Through 2046
Interparfums and Marquee Brands extended the Roberto Cavalli fragrance license to 2046 after 8% H1 brand sales growth, but royalty terms remain undisclosed.
Topic
Licensing
Topic
Licensing
Sobi's $75 Million Upfront Buys Innate Pharma Time Until 2028
Innate Pharma closed its lacutamab deal with Sobi, triggering a $75 million upfront payment and a funding runway into Q1 2028 des…
Butterfly Network Jumps 22% on Needham Buy Rating
Butterfly Network surged 21.99% to $9.93 after Needham launched coverage with a Buy rating and $10 target, while hedge fund holdi…